Letter from Respondent Cobalt to attn: Adam Jacobs, Law Clerk dated 17-NOV-2014 enclosing USB containing materials Cobalt will rely on for the hearing. received on 17-NOV-2014

Acknowledgment of Receipt received from Applicant, Respondents - fax confirmation report with respect to Order, doc 57 placed on file on 24-APR-2015

Order dated 23-APR-2015 rendered by The Honourable Mr. Justice O'Reilly Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant dated 22-APR-2015 re: consent to prohibition order Result: 1. The respondent Minister of Health is prohibited from issuing a Notice of Compliance (NOC) to the respondent Cobalt Pharmaceuticals Company, now known as Actavis Pharma Company ("Cobalt"), in respect of its 9.0mg/5cm2 and 18.0mg/10cm2 rivastigmine patches for transdermal administration until the expiry of the Canadian Patent 2,315,784 or such earlier date upon which the owners of the patent notify the Minister of Health in writing of its consent to the making, constructing, using or selling of the drug in Canada by Cobalt. 2. Cobalt shall pay to Novartis Pharmaceuticals Canada Inc., Novartis AG and LTS Lohmann Therapie-Systeme AG costs in the amount of $150,000. Filed on 23-APR-2015 copies sent to parties entered in J. & O. Book, volume 1264 page(s) 377 - 379 Interlocutory Decision

Consent on behalf of all parties to attached Draft Prohibition Order, further to Court Order of 10-APR-2015; filed on 22-APR-2015

Letter from Applicant dated 22-APR-2015 further to Order of the Court rendered 10-APR-2015 enclosing a Prohibition Order ON CONSENT; received on 22-APR-2015

Confirmation of successful transmission by fax on behalf of all parties with regard to the Order dated April 10, 2015. placed on file on 10-APR-2015

Order dated 10-APR-2015 rendered by The Honourable Mr. Justice O'Reilly Matter considered without personal appearance The Court's decision is with regard to Letter from Respondent dated 09-APR-2015 re: Joint request to extend the time limit in paragraph 7(1)(e) of the PM(NoC) regulations. Result: granted The time limit is extended to April 24, 2015. Filed on 10-APR-2015 copies sent to parties entered in J. & O. Book, volume 1263 page(s) 159 - 160 Interlocutory Decision

Letter from Respondent, Cobalt Pharmaceuticals Company, dated 09-APR-2015 requesting an extension of time ON CONSENT to 24-APR-2015 in order to seek a resolution with attached Draft Order; received on 09-APR-2015

Order dated 26-MAR-2015 rendered by The Honourable Mr. Justice O'Reilly Matter considered without personal appearance The Court's decision is with regard to Case Management Conference Result: "1. This Court orders that the time limit referred to in paragraph 7(1)(e) of the Patented Medicines (Notice of Compliance) Regulations shall be further extended to April 10, 2015." Filed on 26-MAR-2015 copies sent to parties entered in J. & O. Book, volume 1262 page(s) 127 - 128 Interlocutory Decision

Acknowledgment of Receipt received from all parties with respect to Direction issued March 11, 2015 placed on file on 12-MAR-2015

Written directions received from the Court: The Honourable Mr. Justice O'Reilly dated 11-MAR-2015 directing that "The time limit referred to in paragraph 7(1)(e) of the Patented Medicines (Notice of Compliance) Regulations is extended to April 10, 2015. An Order to this effect will be issued withing 30 days." placed on file on 11-MAR-2015 Confirmed in writing to the party(ies)

Ottawa 11-MAR-2015 BEFORE The Honourable Mr. Justice O'Reilly Language: E Before the Court: Meeting Result of Hearing: all parties to provide consent to an extension of time re: settlement discussions with the Court to issue a Direction thereafter; held by way of Conference Call Duration per day: 11-MAR-2015 from 11:02 to 11:05 Courtroom : Judge's Chambers - Ottawa Court Registrar: Anil Kamal Total Duration: 3min Appearances: Mr. Nicholas Wong (416) 941-9440 representing Respondent, Cobalt Pharmaceuticals Co. Comments: DARS Z005576 was used; Minutes of Hearing entered in Vol. 923 page(s) 482 - 483 Abstract of Hearing placed on file

Confirmation of successful transmission by fax on behalf of all parties with regard to the Order dated February 16, 2015. placed on file on 17-FEB-2015

Order dated 16-FEB-2015 rendered by The Honourable Mr. Justice O'Reilly Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant dated 13-FEB-2015 re: Extension of the 24 month stay. Result: granted THIS COURT ORDERS that: 1. the time limit referred to in paragraph 7(1)(e) of the Patented Medicines (Notice of Compliance) Regulations shall be extended to March 17, 2015. Filed on 16-FEB-2015 copies sent to parties entered in J. & O. Book, volume 1258 page(s) 264 - 265 Interlocutory Decision

Draft Order concerning extension of the period referred to in section 7(1)(e)of the Regulations... received on 13-FEB-2015

Letter from Applicant dated 13-FEB-2015 on behalf of all the parties and further to the conference call held on February 10, 2015 before Mr. Justice O'Reilly...(scanned to presiding Judge) received on 13-FEB-2015

Toronto 10-FEB-2015 BEFORE The Honourable Mr. Justice O'Reilly Language: E Before the Court: Meeting Result of Hearing: Judge informs parties that if there is no communication with the Court before March 17, 2015 there will be a Judgment with reasons to follow held by way of Conference Call in chambers Duration per day: 10-FEB-2015 from 09:00 to 09:05 Courtroom : Judge's Chambers - Toronto Court Registrar: John Gornick Total Duration: 5min Appearances: Mr. Tony Creber 613-786-0140 representing Applicant Mr. John Norman 613-786-0140 representing Applicant Mr. Douglas N. Deeth 905-845-4287 representing Respondent - Cobalt Pharmaceuticals Comments: Judge informs parties that if there is no communication with the Court before March 17, 2015, there will be a Judgment with reasons to follow. This meeting was not recorded as per Judge's request. Minutes of Hearing entered in Vol. 921 page(s) 466 - 467 Abstract of Hearing placed on file

Letter from Applicant dated 09-FEB-2015 "...we can advise that Mr. Creber and Mr. Norman are available at 9:00a.m. on February 10th for a teleconference with the Court..." received on 09-FEB-2015

Letter from Mr. Deeth for the Respondent (Cobalt Pharmaceuticals Company) dated 09-FEB-2015 "...This will confirm that I am available for a conference call with the Court on Tuesday, February 10, 2015 at 9:00 a.m..." received on 09-FEB-2015

Letter from Respondent dated 04-FEB-2015 ..."This matter was heard on November 20,2 014 and the decision is under reserve...We recently provided the Applicant with a proposal to settle this matter, which is under consideration. As a result, we respectfully request that the Honourable Mr. Justice O'Reilly not render his decision until March 17, 2015..." (scanned and sent to Mr. Justice O'Reilly) received on 05-FEB-2015

Confirmation of successful transmission by fax on behalf of all parties with regard to the Order dated January 15, 2014. placed on file on 15-JAN-2015

Order dated 15-JAN-2015 rendered by The Honourable Mr. Justice O'Reilly Matter considered without personal appearance The Court's decision is with regard to Motion in writing Doc. No. 48 Result: granted THIS COURT ORDERS that: 1. The time limit referred to in paragraph 7(1)(e) of the PMNOC Regulations shall be extended to February 17, 2015. Filed on 15-JAN-2015 copies sent to parties entered in J. & O. Book, volume 1255 page(s) 137 - 138 Interlocutory Decision

Solicitor's certificate of service on behalf of John Norman confirming service of documents 48 and 49 upon all parties by telecopier on 14-JAN-2015 filed on 14-JAN-2015

Covering letter from Applicant dated 14-JAN-2015 concerning Doc. Nos. 48 49 placed on file on 14-JAN-2015

Draft Order concerning Motion Doc. No. 48 received on 14-JAN-2015

Consent on behalf of Applicant Respondent to an Order in the form attached to the consent extending the 24 month stay to February 17, 2015. filed on 14-JAN-2015

Notice of Motion on behalf of Applicant in writing to be placed before the Court in Ottawa for an Order extending the period referred to in section 7(1)(e) of the PMNOC Regulations to February 17, 2015. filed on 14-JAN-2015 Draft Order\\Judgment received.

Letter from Applicant to Mr. Justice O'Reilly dated 12-JAN-2015 "(...) However, if it is unlikely that a decision will be rendered before the 24 months expires on February 4, 2015, we respectfully request that this be brought to the attention of the parties so that a motion can be brought seeking an extension of the 24-month period, if necessary." received on 12-JAN-2015

Supplemental book of Authorities consisting of 1 volume(s) on behalf of Respondent, Cobalt Pharmaceuticals Company (Received at hearing) received on 17-NOV-2014

Ottawa 20-NOV-2014 BEFORE The Honourable Mr. Justice O'Reilly Language: E Before the Court: Judicial Review Result of Hearing: Matter reserved held in Court Senior Usher: Sean Young Duration per day: 17-NOV-2014 from 09:31 to 04:43 Courtroom : East Courtroom - Supreme Court of Canada Court Registrar: Sherley Desir 18-NOV-2014 from 09:29 to 03:52 Courtroom : East Courtroom - Supreme Court of Canada Court Registrar: Sherley Desir 20-NOV-2014 from 09:28 to 10:55 Courtroom : East Courtroom - Supreme Court of Canada Court Registrar: Sherley Desir Total Duration: 2.5d Appearances: Mr. Anthony Creber (613) 786-0140 representing Applicant Mr. John Norman (613) 783-8848 representing Applicant Mr. Alex Gloor (613) 786-0172 representing Applicant Mr. Douglas N. Deeth (416) 941-9440 representing Respondent, Cobalt Pharmaceuticals Company Ms. Heather E. Watts (416) 941-9440 representing Respondent, Cobalt Pharmaceuticals Company Mr. Nicholas J. Wong (416) 941-9440 representing Respondent, Cobalt Pharmaceuticals Company Comments: - Day Book ( 2 volumes) submitted by the Applicant - Novartis Outline of Argument (Submitted at the hearing) - Loose case law submitted by the Applicant - Compendium (4 volumes) submitted by the Responent, Cobalt Pharmaceuticals - Supplemental Book of Authorities submitted by Cobalt Pharmaceuticals - Cobalt's Outline of Argument submitted at the hearing DARS was used at this hearing. Training laptop Z005714. Minutes of Hearing entered in Vol. 917 page(s) 214 - 233 Abstract of Hearing placed on file

Cobalt's Outline of Argument received at hearing on 18-NOV-2014

Compendium, (4 volumes)_ Submitted by the Respondent, Cobalt Pharmaceuticals Company received at hearing on 18-NOV-2014

Novartis's Outline of Argument received at hearing on 17-NOV-2014

Day Book of the Applicant, Novartis, submitted in 2 volumes at the hearing on November 17, 2014. received on 17-NOV-2014

Letter from Applicant dated 12-NOV-2014 "We write with regard to the applicant's confidential version of its Memorandum of Fact and Law as found at volume 19, Tab 176, of the Applicants' Application Record. In preparing for the hearing the applicant discovered that the text portion of its confidential memorandum was inadvertently reduced when the confidential header was inserted into the PDF version of this document. The public version of the applicant's memorandum is not affected. We enclosed herewith 3 full-sized copies of volume 19, otherwise identical to the previous filed version." received on 12-NOV-2014

Covering letter from Applicant, Novartis Pharmaceuticals Canada Inc., dated 10-NOV-2014 concerning A's Book of Authorities with service placed on file on 10-NOV-2014

Solicitor's certificate of service on behalf of Alex Gloor confirming service of A's Supplemental Book of Authorities upon all parties by personal service on 10-NOV-2014 filed on 10-NOV-2014

Supplemental Book of Authorities consisting of 1 volume(s) on behalf of Applicant, Novartis Pharmaceuticals Canada Inc., received on 10-NOV-2014 Sent directly to Presiding Judge

Letter from Applicant dated 29-OCT-2014 enclosing a USB key containing the Application Record and Book of Authorities; sent to presiding judge's law clerk; received on 29-OCT-2014

Letter from RESPONDENT, COBALT PHARMACEUTICALS CO. dated 28-OCT-2014 AS REQUESTED BY PRESIDING JUDGE IN THIS PROCEEDING, ATTACHED USB KEY CONTAINING COPIES OF MATERIALS FILED THUS FAR...DIRECTED TO LAW CLERK IN TORONTO (A.JACOBS) received on 28-OCT-2014

Solicitor's certificate of service on behalf of NICHOLAS WONG confirming service of DOC 45 AND COBALT'S BOOK OF AUTHORITIES upon all parties by COURIER AND HAND DELIVERY on 19-SEP-2014 filed on 22-SEP-2014

Book of Authorities consisting of 1 volume(s) on behalf of Cobalt (Respondent) received on 22-SEP-2014

Cobalt's Application Record Number of copies received/prepared: 3 on behalf of Respondent filed on 22-SEP-2014

Acknowledgment of Receipt received from all parties with respect to the decision of the Court dated 8-Aug-2014 placed on file on 11-AUG-2014

Solicitor's certificate of service on behalf of Alex Gloor confirming service of doc. no. 43 and Book of Authorities upon the Respondent, Cobalt Pharmaceuticals Company by hand on 07-AUG-2014 confirming service doc. no. 43 and Book of Authorities upon the Respondent, the Minister of Health by hand on 07-AUG-2014 confirming service doc. no. 43 and Book of Authorities upon the Respondent/Patentees, LTS Lohmann Therapie-Systeme AG and Novartis AG by personal service on 07-AUG-2014 filed on 07-AUG-2014

Book of Authorities consisting of 4 volume(s) on behalf of Applicant received on 07-AUG-2014

Public Version of volumes 2, 4, 5, 6, 7, 15, 16 and 19 of doc. no. 43 Located in Annexes I, J and K received on 07-AUG-2014

Applicant's Record (19 vols. partially sealed) Number of copies received/prepared: 3 on behalf of Applicant-vols. 2, 4, 5, 6, 7, 15, 16 & 19 =CONFIDENTIAL (+ public versions) filed on 07-AUG-2014 Document placed in Annexes B C D E VA VB VC VD

Order dated 08-AUG-2014 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant dated 06-AUG-2014 Result: 1. The Applicant Novartis Pharmaceuticals Canada Inc. and the Respondent Cobalt Pharmaceuticals Company are granted leave to file memoranda of fact and law not to exceed 35 pages in lenght, exclusive of Part V and appendices. 2. The Applicant's Record may be filed within 2 days of this Order. 3. There shall be no costs awarded Filed on 08-AUG-2014 copies sent to parties entered in J. & O. Book, volume 1239 page(s) 280 - 281 Interlocutory Decision

Communication to the Court from the Registry dated 07-AUG-2014 re: letter and draft Order received from the Applicant on 6-AUG-2014

Letter from Applicant dated 06-AUG-2014 requesting leave of the Court on consent to allow Novartis and Cobalt to file memoranda of fact and law that exceed the 30 page limit. A draft Order is attached. received on 06-AUG-2014

Acknowledgment of Receipt received from all parties with respect to Order of the Court doc. 77 placed on file on 01-AUG-2014

Order dated 31-JUL-2014 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant dated 28-JUL-2014 Result: granted "UPON the consent of the parties: THIS COURT ORDERS that: 1. Novartis' Application Record shall be served and filed by August 7, 2014. 2. Cobalt's Application Record shall be served and filed by September 22, 2014." Filed on 31-JUL-2014 entered in J. & O. Book, volume 1238 page(s) 448 - 449 Interlocutory Decision

Communication to the Court from the Registry dated 30-JUL-2014 re: Transmitting the Plaintiff's letter and draft order received on July 28, 2014 to the Case Management Judge.

Draft Order concerning Applicant's letter dated July 28,2014 received on 28-JUL-2014

Letter from Applicant dated 28-JUL-2014 "...We write with Cobalt's consent to slightly amend the schedule for the service and filin go of the parties' application records in this proceeding in accordance with the attached draft order." received on 28-JUL-2014

Acknowledgment of Receipt received from all parties with respect to Order Doc. 40 placed on file on 20-FEB-2014

Order dated 20-FEB-2014 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant dated 12-FEB-2014 Result: granted "1. Cobalt shall serve its responding evidence on infringement by 10-MAR-2014. 2. Novartis shall serve its responding affidavit evidence on invalidity by 10-MAR-2014. 3. A full Motion Record on any Motion for reply shall be filed by 17-MAR-2014. Such Motion shall be accompanied by a proposed schedule for filing the responding material, the expected duration of the hearing and both counsel's places and dates of availability for a hearing. 4. Cross-examinations shall be completed by 16-JUN-2014. 5. Novartis' Application Record shall be served and filed by 31-JUL-2014. 6. Cobalt's Application Record shall be served and filed by 15-SEP-2014." Filed on 20-FEB-2014 copies sent to parties entered in J. & O. Book, volume 1220 page(s) 415 - 416 Interlocutory Decision

Communication to the Court from the Registry dated 12-FEB-2014 re: letter dated 12-FEB-2014

Letter from Applicant dated 12-FEB-2014 on behalf of the parties, jointly requesting minor amendments to the current schedule. Draft order attached. received on 12-FEB-2014

Affidavit of service of Thomas Wong sworn on 03-JAN-2014 on behalf of Applicant confirming service of Cobalts affidavit evidence upon all parties by personal service on 03-JAN-2014 filed on 03-JAN-2014

Solicitor's certificate of service on behalf of Alex Gloor confirming service of Affidavit of Evidence of the Applicant, Affidavits of Peter Waibel, Stuart Wright, Erin McIntomny, Richard Guy, Martyn Davies upon Respondent, Cobalt Pharmaceuticals Company, Minister of Health by Electronically on consent with a hard copy to follow by courier on 15-NOV-2013 confirming service of the above documents upon Respondent/Patentees, LTS Lohmann Therapie-Systeme AG and Novartis AG by personal service on 15-NOV-2013 filed on 15-NOV-2013

Acknowledgment of Receipt received from Both parties by facsimile transmission report with respect to Doc. 37 placed on file on 12-NOV-2013

Order (time and place) dated 12-NOV-2013 rendered by Chief Justice Crampton and signed by Judicial Administrator fixing Judicial Review (s.18) to be heard at Special Sitting in Ottawa on 17-NOV-2014 to begin at 09:30 duration: 4d language: E Filed on 12-NOV-2013 cc's sent to parties entered in J. & O. Book, volume 1209 page(s) 458 - 459 Transmittal letters placed on file

Communication to the Court from the Registry dated 22-OCT-2013 re: File sent to TrialJA to set down hearing date

Solicitor's certificate of service on behalf of Alex Gloor confirming service of Doc. #35 upon Respondent - Cobalt Pharmaceuticals Company by telecopier on 18-OCT-2013 confirming service Doc. #35 upon Respondent - Minister of Health by telecopier on 18-OCT-2013 confirming service Doc. #35 upon Respodent/Patentees, LTS Lohmann Therapie-Systeme AG and Novartis AG by personal service on 18-OCT-2013 filed on 18-OCT-2013

Requisition for hearing - Application from Applicant filed on 18-OCT-2013 Tariff Application or appeal - $50.00

Acknowledgment of Receipt received from all parties with respect to Order Doc. 34 placed on file on 01-OCT-2013

Order dated 01-OCT-2013 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant dated 26-SEP-2013 re: draft order resolving Motion Doc. 19 Result: granted "1. Novartis shall serve its factual evidence on invalidity by 20-SEP-2013. 2. A Requisition for Hearing shall be filed by 21-OCT-2013. 3. Novartis shall serve its affidavit evidence on infringement by 15-NOV-2013. 4. Cobalt shall serve its affidavit evidence on invalidity by 3-JAN-2014. 5. Cobalt shall serve its responding evidence on infringement by 25-FEB-2014. 6. Novartis shall serve its responding evidence on invalidity by 25-FEB-2014. 7. A full Motion Record on any Motion for reply shall be filed by 7-MAR-2014. Such Motion shall be accompanied by a proposed schedule for filing the responding material, the expected duration of the hearing and both counsel's places and dates of availability for a hearing. 8. Cross-examinations shall be completed by 16-JUN-2014. 9. Novartis's Application Record shall be served and filed by 31-JUL-2014. 10. Cobalt's Application Record shall be served and filed by 15-SEP-2014." Filed on 01-OCT-2013 copies sent to parties entered in J. & O. Book, volume 1206 page(s) 161 - 162 Interlocutory Decision

Communication to the Court from the Registry dated 27-SEP-2013 re: letter received from the Applicants dated 26-SEP-2013

Letter from Applicant dated 26-SEP-2013 advising that the parties have settled the motion for a schedule to be heard on September 30, 2013 and attaching a draft Order on consent. The parties are still available on September 30, 2013 to speak to the draft Order. received on 26-SEP-2013

Solicitor's certificate of service on behalf of John Norman confirming service of the affidavit of Harry Thiemessen and Frank Theobald upon all parties by courier to Cobalt Pharmaceuticals and by-hand to Minister and Respondent/Pat on 20-SEP-2013 filed on 20-SEP-2013

Affidavit of service of Alex Gloor sworn on 20-SEP-2013 on behalf of Applicant confirming service of the Book of authorities for motion for an extension of time upon all parties by courier on 18-SEP-2013 filed on 23-SEP-2013

Book of Authorities consisting of 1 volume(s) on behalf of Applicant received on 23-SEP-2013

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 20-SEP-2013 directing that "The only time in which the Court is available on any of the 3 days proposed is at 12h00 on September 30, 2013, in Ottawa, for a duration not exceeding one and a half hours. Unless the parties advise otherwise and provide alternative dates of mutual availability by September 25, 2013, that date, time and place will be fixed. The responding record must be served and filed no later than September 26, 2013." placed on file on 20-SEP-2013 Confirmed in writing to the party(ies)

Confidentiality Order (amended) dated 20-SEP-2013 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant dated 19-SEP-2013 re: requesting amendment to the Confidentiality Order of May 13, 2013 on consent Result: granted Filed on 20-SEP-2013 copies sent to parties entered in J. & O. Book, volume 1205 page(s) 268 - 271 Interlocutory Decision

Protective Order (amended) dated 20-SEP-2013 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant dated 19-SEP-2013 re: requesting amendments to the Protective Order of May 13, 2013 on consent Result: granted Filed on 20-SEP-2013 copies sent to parties entered in J. & O. Book, volume 1205 page(s) 259 - 267 Interlocutory Decision

Communication to the Court from the Registry dated 20-SEP-2013 re: letter from the Applicant's counsel dated September 19, 2013

Letter from Applicant dated 19-SEP-2013 requesting on consent amendments to the Protective Order and Confidentiality Order. A copy of a decision from the US District Court, Central District of California, a draft amended Protective Order and a draft amended Confidentiality Order are attached. received on 19-SEP-2013

Communication to the Court from the Registry dated 19-SEP-2013 re: scheduling of Motion Doc. 19

Solicitor's certificate of service on behalf of Alex Gloor confirming service of Doc. No. 27 upon all parties by personal service on 18-SEP-2013 filed on 17-SEP-2013

Motion Record Number of copies received: 1 on behalf of Applicant, 2 volumes, (PUBLIC VERSION OF CONFIDENTIAL DOC. NO. 27) filed on 17-SEP-2013

Motion Record containing the following original document(s): 21 22 23 24 25 26 Number of copies received: 3 on behalf of Applicant, 2 volumes, (CONFIDENTIAL- SEALED ENVELOPE)_ filed on 17-SEP-2013

Written Representations (CONDFIDENTIAL) contained within a Motion Record on behalf of Applicant concerning Motion Doc. No. 19 filed on 17-SEP-2013

Supplementary Affidavit of Erin McIntomny (CONFIDENTIAL) sworn on 17-SEP-2013 contained within a Motion Record on behalf of Applicant in support of Motion Doc. No. 19 with Exhibits "A" filed on 17-SEP-2013

Affidavit of Dr. Martyn Davies (CONFIDENTIAL) sworn on 17-SEP-2013 on behalf of Applicant in support of Motion Doc. No. 19 filed on 17-SEP-2013

Affidavit of Peter Waibel (CONFIDENTIAL) sworn on 16-SEP-2013 contained within a Motion Record on behalf of Applicant in support of Motion Doc. No. 19 with Exhibits "A"-"B" filed on 17-SEP-2013

Affidavit of Stuart Wright (CONFIDENTIAL) sworn on 16-SEP-2013 contained within a Motion Record on behalf of Applicant in support of Motion Doc. No. 19 with Exhibits "A" filed on 17-SEP-2013

Affidavit of Erin McIntomny (CONFIDENTIAL) sworn on 16-SEP-2013 contained within a Motion Record on behalf of Applicant in support of Motion Doc. No. 19 with Exhibits "A"-"NN" filed on 17-SEP-2013

Covering letter from Applicant dated 13-SEP-2013 concerning Doc. Nos. 19 20 placed on file on 13-SEP-2013

Solicitor's certificate of service on behalf of John Norman confirming service of Notice of Motion doc.19 upon Respondents and Respondent/Patentees by fax and personal service upon Respondent/Patentees on 13-SEP-2013 filed on 13-SEP-2013

Notice of Motion on behalf of Applicant returnable (but no hearing date indicated at this time) for an Order 1.varying the schedule in this proceeding as set out in Schedule A hereto; 2.pursuant to s.6(7) of Patented Medicines (NOC) compelling the Respondent Cobalt to produce samples of its rivastigmine patches;3.requiring the Minister to verify that Cobalt-rivastigmine patches and portions of Cobalt's ANDS documents produced corresponds fully to the information in the ANDS filed by Cobalt with respect to its rivastigmine patche products; 4. costs filed on 13-SEP-2013

Acknowledgment of Receipt received from all parties with respect to Order Doc. 18 Transmitted by e-mail on 9-SEP-2013: receipt acknowledged by the Applicant and the Respondent Cobalt Pharmaceuticals Company on 9-SEP-2013; by the Respondent Minister of Health on 10-SEP-2013 placed on file on 09-SEP-2013

Order dated 06-SEP-2013 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant dated 09-AUG-2013 Result: granted "1. Novartis shall serve its affidavit evidence on infringement and factual evidence on invalidity by 20-SEP-2013. 2. Cobalt shall serve its affidavit evidence on invalidity and responding evidence on infringement by 16-DEC-2013. 3. A Requisition for Hearing shall be filed by 16-DEC-2013. 4. Novartis shall serve its responding affidavit evidence on invalidity by 7-APR-2014. 5. A full Motion Record on any Motion for reply shall be filed by 16-APR-2014. Such Motion shall be accompanied by a proposed schedule for filing the responding material, the expected duration of the hearing and both counsel's places and dates of availability for a hearing. 6. Cross-examinations shall be completed by 16-JUN-2014. 7. Novartis' Application Record shall be served and filed by 18-AUG-2014. 8. Cobalt's Application Record shall be served and filed by 16-OCT-2014." Filed on 06-SEP-2013 copies sent to parties entered in J. & O. Book, volume 1204 page(s) 46 - 47 Interlocutory Decision

Communication to the Court from the Registry dated 09-AUG-2013 re: letter to the Court dated 9-AUG-2013

Letter from Applicant dated 09-AUG-2013 requesting extensions to the Scheduling Order on consent. A draft Order is attached. received on 09-AUG-2013

Acknowledgment of Receipt received from all parties (by EMAIL) with respect to the Direction of the Court dated 1-AUG-2013 placed on file on 01-AUG-2013

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 01-AUG-2013 directing that "Counsel's letter does not indicate whether the parties have exchanged or discussed, following July 3, 2013, any proposal for a schedule Novartis to proceed with a motion under s. 6(7) or to complete the US procedure, and subsequently, for serving its evidence, nor does the offer any details of either party's views of an appropriate schedule view of the current state of affairs. In the circumstances, a case management telephone conference is premature. The parties should discuss appropriate extension of time for Novartis to serve its factual evidence on invalidity and/or its evidence on infringement, as well as for any additional or other step leading to or flowing from it. The Court can assist the parties in devising a mutually acceptable schedule, but the parties should, before having recourse to the Court, have discussed the matter and identified the issues on which there is disagreement. Further, should it appear that the matter of an extension of time is sufficiently contested that it will require a motion, then Novartis should serve and file a motion record to that effect." placed on file on 01-AUG-2013 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 01-AUG-2013 re: letter received from the applicants on July 31, 2013

Letter from Applicant dated 31-JUL-2013 providing an update on the status of this proceeding and requesting a case management telephone conference to discuss extensions to the schedule. received on 31-JUL-2013

Acknowledgment of Receipt received from all parties with respect to Order Doc. 17 Transmitted by e-mail on 21-JUN-2013: receipt acknowledged by the Applicant and the Respondent Cobalt Pharmaceuticals Company on 21-JUN-2013; by the Respondent Minister of Health on 24-JUN-2013. placed on file on 24-JUN-2013

Order dated 21-JUN-2013 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant dated 13-JUN-2013 Result: granted in part "1. Novartis shall serve its affidavit evidence on infringement and factual evidence on invalidity by 6-AUG-2013. 2. Cobalt shall serve its affidavit evidence on invalidity and responding evidence on infringement by 1-NOV-2013. 3. A Requisition for Hearing shall be filed by 1-NOV-2013. 4. Novartis shall serve its responding affidavit evidence on invalidity by 21-FEB-2014. 5. A full Motion Record on any Motion for reply shall be filed by 2-MAR-2014. Such Motion shall be accompanied by a proposed schedule for filing the responding material, the expected duration of the hearing and both counsel's places and dates of availability for a hearing. 6. Cross-examinations shall be completed by 2-MAY-2014. 7. Novartis' Application Record shall be served and filed by 4-JUL-2014. 8. Cobalt's Application Record shall be served and filed by 1-SEP-2014." Filed on 21-JUN-2013 copies sent to parties entered in J. & O. Book, volume 1197 page(s) 210 - 211 Interlocutory Decision

Communication to the Court from the Registry dated 13-JUN-2013 re: Letter dated 13-JUN-2013

Letter from Applicant dated 13-JUN-2013 with the agreement of the parties, requesting amendments to the Scheduling Order dated 27-FEB-2013 received on 13-JUN-2013

Acknowledgment of Receipt received from all parties with respect to Protective Order Doc. 15 and Confidentiality Order Doc. 16 placed on file on 13-MAY-2013

Confidentiality Order dated 13-MAY-2013 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant dated 09-MAY-2013 Result: granted 1. The following information of Cobalt relating to its Abbreviated New Drug Submission for rivastigmine may be filed and treated as confidential.... 2. Whenever a party seeks to file in this Court documents or portions thereof, including affidavits, exhibits, transcripts or motion materials which contain or discuss confidential information, as defined in paragraph 1 of this Order ("Confidential Information"), in a manner that would reveal its content, the Confidential Information shall be segregated from other information and documentation being submitted for filing and shall be submitted to the Court in sealed envelopes identifying this proceeding and permanently marked with the following legend... 3. Where it is not reasonably practical to segregate Confidential Information from non-confidential information, the parties may file an entire document or volume thereof in a sealed envelope, provided that a public version of the document or volume, from which Confidential Information has been redacted or removed, is also filed on the public record... Filed on 13-MAY-2013 copies sent to parties entered in J. & O. Book, volume 1193 page(s) 17 - 19 Interlocutory Decision

Protective Order dated 13-MAY-2013 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant dated 09-MAY-2013 Result: granted Filed on 13-MAY-2013 copies sent to parties entered in J. & O. Book, volume 1193 page(s) 9 - 16 Interlocutory Decision

Communication to the Court from the Registry dated 13-MAY-2013 re: letter dated 13-MAY-2013

Letter from Applicant dated 09-MAY-2013 enclosing draft protective and confidentiality orders consented to by all parties; requesting that the orders be issued without the necessity of a formal motion. received on 09-MAY-2013

Acknowledgment of Receipt received from all parties with respect to Order Doc. 14 placed on file on 28-FEB-2013

Order dated 27-FEB-2013 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant dated 22-FEB-2013 Result: granted 1. Cobalt shall provide its productions from its ANDS (Cobalt rivastigmine formulation and properties) by 4-MAR-2013. 2. Novartis shall serve and file a full Motion Record on any Motion pursuant to s. 6(7) by 2-APR-2013, if required. The record shall be accompanied by a letter setting out a proposed schedule for filing the responding material, the expected duration of the hearing and both counsel's places and dates of availability for a hearing. 3. Novartis shall serve its affidavit evidence on infringement and factual evidence on invalidity by 5-JUL-2013. 4. Cobalt shall serve its affidavit evidence on invalidity and responding evidence on infringement by 1-OCT-2013. 5. A Requisition for Hearing shall be filed by 1-OCT-2013. 6. Novartis shall serve its responding affidavit evidence on invalidity by 17-JAN-2014. 7. A full Motion Record on any Motion for reply shall be filed by 31-JAN-2014. Such Motion shall be accompanied by a proposed schedule for filing the responding material, the expected duration of the hearing and both counsel's places and dates of availability for a hearing. 8. Cross-examinations shall be completed by 2-MAY-2014. 9. Novartis' Application Record shall be served and filed by 4-JUL-2014. 10. Cobalt's Application Record shall be served and filed by 1-SEP-2014. Filed on 27-FEB-2013 copies sent to parties entered in J. & O. Book, volume 1185 page(s) 210 - 212 Interlocutory Decision

Communication to the Court from the Registry dated 25-FEB-2013 re: Letter dated 22-FEB-2013

Letter from Applicant dated 22-FEB-2013 submitting a proposed schedule jointly with the Respondent Cobalt Pharmaceuticals Company for further steps to be taken in the Application received on 22-FEB-2013

Letter from Applicant dated 14-FEB-2013 providing a status update. The Applicant would like to advise the Court that the parties are currently engaged in discussions pertaining to the next steps in this application...The Applicant proposes to report back to the Court on or before Feb. 22, 2013. received on 14-FEB-2013

Solicitor's certificate of service on behalf of Cristin Wagner confirming service of the Notice of Appearance of LTS Lohmann Therapie-Systeme AG upon Applicant by personal service on 13-FEB-2013 confirming service the Notice of Appearance of LTS Lohmann Therapie-Systeme AG upon Respondents, Cobalt Pharmaceuticals Company and the Minister of Health by telecopier on 13-FEB-2013 confirming service the Notice of Appearance of LTS Lohmann Therapie-Systeme AG upon Respondent/Patentee, Novartis AG by personal service on 13-FEB-2013 filed on 13-FEB-2013

Notice of appearance on behalf of Respondent Patentee, LTS Lohmann Therapie-Systeme AG filed on 13-FEB-2013

Solicitor's certificate of service on behalf of Cristin Wagner confirming service of the Notice of Appearance of Novartis AG upon Applicant by personal service on 13-FEB-2013 confirming service the Notice of Appearance of Novartis AG upon Respondents, Cobalt Pharmaceuticals Company and the Minister of Health by telecopier on 13-FEB-2013 confirming service the Notice of Appearance of Novartis AG upon Respondent/Patentee, LTS Lohmann Therapie-Systeme AG by personal service on 13-FEB-2013 filed on 13-FEB-2013

Notice of appearance on behalf of Respondent Patentee, Novartis AG filed on 13-FEB-2013

Affidavit of service of Marcail Delahunt sworn on 13-FEB-2013 on behalf of Applicant confirming service of the Notice of Application upon Respondent, Minister of Health, Respondents/Patentees, Novartis AG and LTS Lohmann Therapie-System AG by personal service on 04-FEB-2013 filed on 13-FEB-2013

Affidavit of service of Mervyn Archdall sworn on 06-FEB-2013 on behalf of Applicant confirming service of the Notice of Application upon Respondent, Cobalt Pharmaceuticals Company by personal service on 05-FEB-2013 filed on 13-FEB-2013

Solicitor's certificate of service on behalf of Cheryl Cheung confirming service of DOC 6 upon all parties by telecopier on 11-FEB-2013 filed on 11-FEB-2013

Notice of appearance on behalf of Respondent - Cobalt Pharmaceuticals Company filed on 11-FEB-2013

Affidavit of service of James Adeney sworn on 06-FEB-2013 on behalf of The Minister of Health confirming service of Doc.4 upon all parties by telecopier on 05-FEB-2013 with Exhibits A filed on 06-FEB-2013

Notice of appearance on behalf of The Minister of Health filed on 06-FEB-2013

Proof of transmission by fax received from all parties with respect to Doc. #3 (Order from CJC dated February 6, 2013) placed on file on 06-FEB-2013

Order dated 06-FEB-2013 rendered by Chief Justice Crampton Matter considered without personal appearance The Court's decision is with regard to Status Review Result: IT IS ORDERED pursuant to Rule 383 that Prothonotary Mireille Tabib is assigned as Case Management Judge in this matter. Filed on 06-FEB-2013 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1182 page(s) 480 - 480 Interlocutory Decision

****** CANCELLED ****** Communication to the Court from the Registry dated 05-FEB-2013 re: Case Management Judge to be assigned

Service copy of Notice of Application with proof of service upon Deputy Attorney General of Canada on 05-FEB-2013 filed on 05-FEB-2013

Notice of application and 2 copies with regard to s. 55.2(4) of the Patent Act and s. 6 of the Patented Medicines (NOC) Regs. filed on 04-FEB-2013 Certified copy(ies)/copy(ies) transmitted to Deputy Attorney General of Canada Tariff fee of $50.00 received: yes